MarketBeatThu, 11 Jun 2026 13:04:06 GMTCapricor Therapeutics Eyes FDA Approval Path for Duchenne Cell TherapyCAPR-0.30%
Seeking AlphaWed, 10 Jun 2026 17:52:11 GMTCapricor Therapeutics, Inc. (CAPR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptCAPR-0.30%
Seeking AlphaWed, 03 Jun 2026 08:43:43 GMTCapricor: I Rate It A Buy After Stress-Testing The Sell ThesisCAPR-0.30%
Seeking AlphaWed, 13 May 2026 02:50:42 GMTCapricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call TranscriptCAPR-0.30%
BenzingaFri, 08 May 2026 13:34:41 GMTCapricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne TherapyCAPR-0.30%
